Results 151 to 160 of about 65,404 (216)

Major histocompatibility complex II serves as a prognostic biomarker in resectable pulmonary sarcomatoid carcinoma: development of a prediction model. [PDF]

open access: yesTransl Lung Cancer Res
Wang H   +16 more
europepmc   +1 more source

Univariate- and machine learning-based plasma metabolite signature differentiates PSC-IBD from IBD and is predicted to be driven by gut microbial changes. [PDF]

open access: yesMetabolomics
Wolthuis JC   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy